8 respiratory therapy milestones using inhaled biological vesicles in 2026
As 2026 unfolds, the pulmonology community is celebrating the arrival of the first inhalable vesicle-based treatments for idiopathic pulmonary fibrosis (IPF). These treatments, delivered via high-efficiency nebulizers, carry anti-fibrotic signals directly to the deep lung tissues, halting the progressive scarring that characterizes the disease. This clinical achievement is currently being...
0 Σχόλια 0 Μοιράστηκε 23 Views 0 Προεπισκόπηση
Lifesone https://lifesone.com